Figure 2
From: Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease

Serum levels of tetranectin (TN) in the study groups.
Results are presented as mean±SEM. (A) Serum levels of TN in healthy controls and CAD patients. (B) Levels of TN in patients with and without significant CAD. A stepwise elevation in the TN levels was found depending on the number of significantly diseased coronary arteries (>50% stenosis). P = 0.009 for trend.